Pyrido[3,4-d]pyrimidin-4(3H)-one metabolism mediated by aldehyde oxidase is blocked by C2-substitution

Angela HayesCancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK

N. Yi MokCancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK

Manjuan LiuCancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK

Ching ThaiCancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK

Alan T. HenleyCancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK

Butrus AtrashCancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK

Rachel M. LaniganCancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK

Jimmy SejbergCancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK

Yann-Vaï Le BihanCancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK

Vassilios BavetsiasCancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK

Julian BlaggCancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK

Florence I. RaynaudCancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UKCorrespondence[email protected]

Related Research Data